Atlas Trials

Sacubitril 97 mg and Valsartan 103 mg Film-coated Tablets Relative to Entresto 97 mg/103 mg Film-coated Tablets

Clinical trial NCT06248112 · UNKNOWN

Trial details

NCT number
NCT06248112
Sponsor
Bio-innova Co., Ltd
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Subjects
Start date
2024-05-06
Primary completion
2024-06-22
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.